Featured News & Highlights
Everest Announces Acquisition of August Research
TORONTO —November 7, 2023—Everest Clinical Research (“Everest”), a leading full-service contract research organization (“CRO”) with deep expertise…
Everest Announces Acquisition of Brightech International
TORONTO – December 1, 2022 – Everest Clinical Research (“Everest”), a leading full-service contract research organization (“CRO”)…
Access clinical trial data visualizations through our Clinical Data Dashboard
By integrating data across disparate systems, insights into trial operations, data integrity and patient information are centralized…
We are ready for an accelerated growth in 2021 and years beyond!
Over the past 16 years we have built a solid foundation for future growth. Our reputation for…
We are on the battlefront fighting against COVID-19!
We are proud to support over a dozen COVID-19 vaccine and therapeutic treatment trials, including high profile…
During COVID-19 pandemic, we continue to perform very well.
During the COVID-19 pandemic, Everest team members are safe and healthy. Our commitment, high performance, and level…
Over 30% of our work is focused on progressing critical cancer research.
Despite the significant advances made in finding treatments for human diseases, there remains an unmet need in…
- « Previous
- 1
- 2
- 3